Workflow
证券欺诈
icon
Search documents
Levi & Korsinsky Reminds Fortinet, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 21, 2025 – FTNT
Globenewswire· 2025-10-31 20:03
Core Viewpoint - A class action securities lawsuit has been filed against Fortinet, Inc. for alleged securities fraud affecting investors between November 8, 2024, and August 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Fortinet's management made false statements regarding the refresh cycle of their products, suggesting it would be more profitable than it actually was [2]. - It is alleged that the refresh cycle consisted of old products that represented only a "small percentage" of Fortinet's overall business [2]. - The complaint also states that Fortinet misrepresented the number of FortiGate firewalls eligible for upgrades and that the refresh momentum was overstated, with only half of the refresh completed by the end of Q2 2025 [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified period have until November 21, 2025, to request appointment as lead plaintiff in the lawsuit [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].
Levi & Korsinsky Reminds Fluor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 14, 2025 – FLR
Globenewswire· 2025-10-31 20:02
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fluor Corporation ("Fluor Corporation" or the "Company") (NYSE: FLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fluor Corporation investors who were adversely affected by alleged securities fraud between February 18, 2025 and July 31, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/fluor-cor ...
Shareholders that lost money on KBR, Inc. (KBR) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
Globenewswire· 2025-10-31 20:02
Core Viewpoint - A class action securities lawsuit has been filed against KBR, Inc. alleging securities fraud that affected investors between May 6, 2025, and June 19, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that KBR, Inc. made false statements regarding its partnership with HomeSafe, despite knowing that the U.S. Department of Defense had concerns about HomeSafe's ability to fulfill a global household goods contract [2] - Defendants allegedly misled investors about KBR's business operations and future prospects, which were claimed to be without issues [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until November 18, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing significant recoveries for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4]
Levi & Korsinsky Reminds WPP Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 – WPP
Globenewswire· 2025-10-31 20:02
Core Viewpoint - A class action securities lawsuit has been filed against WPP plc, alleging securities fraud that negatively impacted investors between February 27, 2025, and July 8, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that WPP provided overly positive statements while concealing material adverse facts about its media arm's ability to handle macroeconomic challenges and competition, leading to a loss of market share [2] - On July 9, 2025, WPP reported a deterioration in performance for Q2 2025, attributing this to macroeconomic uncertainty and weaker new business, partly due to ongoing restructuring within WPP Media [2] - Following the trading update, WPP's stock price fell from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, marking an approximate decline of 18.1% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]
涉案金额460亿元,受理案件10942件!中证协、北京金融法院最新发布
券商中国· 2025-10-31 02:28
Core Viewpoint - The report highlights the increasing number of securities-related disputes in Beijing, emphasizing the prevalence of securities fraud cases and the expanding range of liable parties involved in these disputes [1][2][3][5]. Group 1: Case Statistics - From March 2021 to August 2025, the Beijing Financial Court accepted a total of 10,942 securities commercial cases, with a significant portion being securities fraud liability disputes [2][3]. - The total amount involved in securities dispute cases reached 45.928 billion yuan, with an average litigation amount of approximately 4.1974 million yuan per case [2][7]. - The number of securities fraud liability disputes accounted for 99.8% of all fraud-related cases, indicating a dominant trend in the types of disputes being filed [4]. Group 2: Types of Disputes - The report categorizes securities fraud liability disputes into four main types: false statements, insider trading, market manipulation, and fraud against clients, with false statements being the most common [4]. - The majority of cases involve false statements related to financial misrepresentation, misleading statements, and failure to disclose critical information [4]. Group 3: Involved Parties - A total of 45 intermediary institutions have been sued, including 11 securities companies, 19 accounting firms, 6 law firms, 5 asset appraisal agencies, and 4 credit rating agencies [5][6]. - The report notes that investors are increasingly suing not only the issuers but also their controlling shareholders, actual controllers, and senior executives, reflecting a trend towards broader accountability [5][6]. Group 4: Emerging Issues - The report identifies new challenges arising from the complexity of financial products and trading models, including potential lawsuits related to companies facing delisting due to fraud [8]. - There is a growing concern regarding large shareholders' illegal share reductions, which may lead to securities fraud claims, especially in light of new regulations governing share reductions [8][9]. - The report anticipates an increase in civil claims related to insider trading and market manipulation as investor awareness and legal frameworks evolve [9].
RCI Hospitality Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 20, 2025 to Discuss Your Rights – RICK
Globenewswire· 2025-10-28 19:40
Core Viewpoint - A class action securities lawsuit has been filed against RCI Hospitality Holdings, Inc. alleging securities fraud affecting investors between December 15, 2021, and September 16, 2025 [1][2]. Case Details - The complaint claims that defendants engaged in tax fraud and bribery to conceal this fraud, leading to an understatement of legal risks for the company [3]. - It is alleged that the defendants' statements regarding the company's business, operations, and prospects were materially false and misleading [3]. Next Steps - Investors who suffered losses during the specified timeframe have until November 20, 2025, to request appointment as lead plaintiff, although participation does not require this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5].
Johnson Fistel Continues Investigation on Behalf of RXO, Inc. (RXO) Shareholders Who Have Incurred Losses
Prnewswire· 2025-10-28 16:44
Core Viewpoint - Johnson Fistel, PLLP is investigating RXO, Inc. for potential violations of federal securities laws related to misrepresentation or failure to disclose material information to investors [1]. Group 1: Investigation Details - The investigation focuses on whether RXO, Inc. or its officers and directors misrepresented or failed to timely disclose material information to investors [1]. - Investors who purchased RXO securities and suffered losses are encouraged to join the investigation [2]. Group 2: About Johnson Fistel, PLLP - Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices across multiple states, representing both individual and institutional investors in securities class action lawsuits [3]. - The firm has been recognized as a top plaintiffs' securities law firm, having recovered approximately $90.725 million for clients in cases where it served as lead or co-lead counsel [4].
MAX SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of MediaAlpha, Inc. (NYSE: MAX) and Encourages Long-Term Investors to Contact the Firm- MAX
Globenewswire· 2025-10-28 14:30
Core Viewpoint - Kaskela Law LLC is investigating MediaAlpha, Inc. on behalf of long-term investors due to a significant decline in the company's stock price and potential violations of securities laws or fiduciary duties by the company's officers and directors [1][3]. Stock Performance - Since February 2024, MediaAlpha's stock has decreased from over $21.00 per share to less than $12.00 per share, representing a cumulative decline of over $9.00 per share, or over 42% in value [2]. Legal Investigation - The investigation aims to determine if MediaAlpha and its executives breached securities laws or fiduciary duties in relation to recent corporate actions [3]. Investor Communication - Current shareholders of MediaAlpha are encouraged to contact Kaskela Law LLC for more information regarding the investigation and their legal rights [4]. Firm Background - Kaskela Law LLC has a history of representing investors in securities fraud and corporate governance cases, having recovered over $500 million for investors since 2020 [4].
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NuScale Power Corporation - SMR
Prnewswire· 2025-10-28 14:00
Group 1 - Pomerantz LLP is investigating claims on behalf of investors of NuScale Power Corporation regarding potential securities fraud or unlawful business practices by the company and its officers/directors [1] - Citigroup downgraded NuScale from Neutral/High Risk to Sell/High Risk on October 21, 2025, citing competition from new entrants and the lack of a binding customer contract [2] - Following the downgrade, NuScale's stock price fell by $9.49 per share, or 21.47%, closing at $34.72 per share on October 22, 2025 [3]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc. - ALEC
Prnewswire· 2025-10-28 14:00
Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Alector, Inc. following disappointing clinical trial results for its drug, latozinemab, which did not meet primary endpoints [1][2]. Group 1: Company Overview - Alector, Inc. is a biotechnology company focused on developing therapies for neurodegenerative diseases [2]. - The company recently announced results from the Phase 3 INFRONT-3 clinical trial for latozinemab, which targets frontotemporal dementia due to a progranulin gene mutation [2]. Group 2: Clinical Trial Results - The Phase 3 clinical trial results indicated that latozinemab failed to meet its clinical co-primary endpoint of slowing the progression of frontotemporal dementia [2]. - Secondary and exploratory endpoints, including fluid biomarkers and volumetric magnetic resonance imaging (vMRI), showed no treatment-related effects [2]. Group 3: Market Reaction - Following the announcement of the trial results, Alector's stock price dropped by $1.60 per share, representing a decline of 49.84%, closing at $1.61 per share on October 22, 2025 [2].